Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices 22207 

meeting agenda will be posted on the 

Committee’s Web site at http://

www.hrsa.gov/advisorycommittees/

rural/. 

Jackie Painter, 

Director, Division of the Executive Secretariat. 

[FR Doc. 2015–09080 Filed 4–20–15; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Advisory Council on the 

National Health Service Corps; Notice 

of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: National Advisory Council on 

the National Health Service Corps 

(NAC). 

Date and Time: May 6, 2015 from 2:00 

p.m.–3:30 p.m. (EST). 

Place: Conference Call Format. 

Status: The meeting will be open to 

the public. 

Purpose: The NAC provides advice to 

the Secretary of the Department of 

Health and Human Services and the 

Administrator of the Health Resources 

and Services Administration (HRSA), 

with respect to their responsibilities for 

designating areas of the United States 

with critical health professional 

shortages (i.e., Health Professional 

Shortage Area) and assigning health care 

personnel to improve the delivery of 

health services in these areas. 

Agenda: The members of the NAC 

will discuss: (a) The activities and goals 

for fiscal year 2016 for the National 

Health Service Corps; (b) their vision 

and approaches for future NAC 

meetings; and (c) planning for an inperson meeting. The official agenda will 

be available 2 days prior to the meeting 

on the HRSA Web site at: http://

nhsc.hrsa.gov/corpsexperience/aboutus/

nationaladvisorycouncil/. Agenda items 

are subject to change as priorities 

dictate. 

Public Comment: Requests to make 

oral comments or provide written 

comments to the NAC should be sent to 

CAPT Shari Campbell, Designated 

Federal Official, using the address and 

phone number below. Individuals who 

plan to participate on the conference 

call should notify CAPT Campbell at 

least 3 days prior to the meeting, using 

the address and phone number below. 

Members of the public will have the 

opportunity to provide comments. 

Interested parties should refer to the 

meeting, in the subject line, as the 

HRSA National Advisory Council on the 

National Health Service Corps. The 

conference call-in number is: 888–566– 

5974. The passcode is: 4439136. 

FOR FURTHER INFORMATION CONTACT: 

Anyone requesting information 

regarding the NAC should contact CAPT 

Shari Campbell, Designated Federal 

Official, Bureau of Health Workforce, 

HRSA, in one of three ways: (1) Send a 

request to the following address: CAPT 

Shari Campbell, Designated Federal 

Official, Bureau of Health Workforce, 

HRSA, Parklawn Building, Room 8C–26, 

5600 Fishers Lane, Rockville, Maryland 

20857; (2) call (301) 594–4251; or (3) 

send an email to scampbell@hrsa.gov. 

Jackie Painter, 

Director, Division of the Executive Secretariat. 

[FR Doc. 2015–09078 Filed 4–20–15; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Submission to OMB for 

Review and Approval; Public Comment 

Request 

AGENCY: Health Resources and Services 

Administration, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the Health 

Resources and Services Administration 

(HRSA) has submitted an Information 

Collection Request (ICR) to the Office of 

Management and Budget (OMB) for 

review and approval. Comments 

submitted during the first public review 

of this ICR will be provided to OMB. 

OMB will accept further comments from 

the public during the review and 

approval period. 

DATES: Comments on this ICR should be 

received no later than May 21, 2015. 

ADDRESSES: Submit your comments, 

including the Information Collection 

Request Title, to the desk officer for 

HRSA, either by email to OIRA_

submission@omb.eop.gov or by fax to 

202–395–5806. 

FOR FURTHER INFORMATION CONTACT: To 

request a copy of the clearance requests 

submitted to OMB for review, email the 

HRSA Information Collection Clearance 

Officer at paperwork@hrsa.gov or call 

(301) 443–1984. 

SUPPLEMENTARY INFORMATION: 

Information Collection Request Title: 

Enrollment and Re-Certification of 

Entities in the 340B Drug Pricing 

Program and Collection of Manufacturer 

Data to Verify 340B Drug Pricing 

Program Ceiling Price Calculations. 

OMB No. 0915–0327—Revision 

Abstract: Section 602 of Public Law 

102–585, the Veterans Health Care Act 

of 1992, enacted as Section 340B of the 

Public Health Service Act (PHS Act; 

‘‘Limitation on Prices of Drugs 

Purchased by Covered Entities’’), 

provides that a manufacturer who sells 

covered outpatient drugs to eligible 

entities must sign a Pharmaceutical 

Pricing Agreement (PPA) with the 

Secretary of Health and Human Services 

in which the manufacturer agrees to 

charge a price for covered outpatient 

drugs that will not exceed an amount 

determined under a statutory formula 

(‘‘ceiling price’’). 

A manufacturer subject to a PPA must 

offer all covered outpatient drugs at no 

more than the ceiling price to a covered 

entity listed in the 340B Program 

database. Manufacturers rely on the 

information in the 340B database to 

determine if a covered entity is 

participating in the 340B Program or for 

any notifications of changes to 

eligibility that may occur within a 

quarter. By signing the PPA, the 

manufacturer agrees to comply with all 

applicable statutory and regulatory 

requirements, including any changes 

that occur after execution of the PPA. 

Covered entities which choose to 

participate in the 340B Program must 

comply with the requirements of 

Section 340B(a)(5) of the PHS Act. 

Section 340B(a)(5)(A) prohibits a 

covered entity from accepting a 

discount for a drug that would also 

generate a Medicaid rebate. Further, 

Section 340B(a)(5)(B) prohibits a 

covered entity from reselling or 

otherwise transferring a discounted drug 

to a person who is not a patient of the 

entity. 

Need and Proposed Use of the 

Information: Section 340B(d)(1)(B)(i) of 

the PHS Act requires the development 

of a system to enable the Secretary to 

verify the accuracy of ceiling prices 

calculated by manufacturers under 

subsection (a)(1) and charged to covered 

entities, which shall include the 

following: 

(I) Developing and publishing through 

an appropriate policy or regulatory 

issuance, precisely defined standards 

and methodology for the calculation of 

ceiling prices under such subsection. 

(II) Comparing regularly the ceiling 

prices calculated by the Secretary with 


tkelley on DSK3SPTVN1PROD with NOTICES